Henry O. Gosebruch

Insider Reports History

Location: 1 N. Waukegan Road, North Chicago, IL
Signature: /s/ Eddie Kim, Attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Henry O. Gosebruch:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
AbbVie Inc.	EVP, Chief Strategy Officer	Common Stock, $0.01 par value	53.5K	$8.28M	$154.72	May 16, 2022	In trust
AbbVie Inc.	EVP, Chief Strategy Officer	Common Stock, $0.01 par value	41.6K	$6.44M	$154.72	May 16, 2022	Direct
Neumora Therapeutics, Inc.	President & CEO, Director	Common Stock	462K	$5.54M	$11.98	Feb 14, 2024	Direct
Neumora Therapeutics, Inc.	President & CEO, Director	Common Stock	127K	$1.53M	$11.98	Feb 14, 2024	Indirect
AbbVie Inc.	EVP, Chief Strategy Officer	Common Stock, $0.01 par value	3.64K	$563K	$154.72	May 16, 2022	Profit sharing trust
ACELYRIN, Inc.	Director	Common Stock	0	$0	$2.45	May 21, 2025	Direct
Neumora Therapeutics, Inc.	President & CEO, Director	Stock Option (Right to Buy)	160K			Feb 14, 2024	Direct
Aptinyx Inc.	Director	Stock Option (Right to Buy)	40K			May 26, 2022	Direct
AbbVie Inc.	EVP, Chief Strategy Officer	Option (Right to Buy)	0		$144.54	May 16, 2022	Direct
ACELYRIN, Inc.	Director	Director Stock Option (right to buy)	0			May 21, 2025	Direct

Showing 1 to 10 of 10 entries

Insider Reports Filed by Henry O. Gosebruch

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SLRN	ACELYRIN, Inc.	May 21, 2025	3	$0	4	May 23, 2025	Director
SLRN	ACELYRIN, Inc.	Jun 7, 2024	1	$0	4	Jun 11, 2024	Director
NMRA	Neumora Therapeutics, Inc.	Feb 14, 2024	2	$0	4	Feb 16, 2024	President & CEO, Director
NMRA	Neumora Therapeutics, Inc.	Sep 19, 2023	1	$189K	4	Sep 19, 2023	President & CEO, Director
NMRA	Neumora Therapeutics, Inc.	Sep 14, 2023	0	$0	3	Sep 14, 2023	President & CEO, Director
SLRN	ACELYRIN, Inc.	May 9, 2023	3	$900K	4	May 11, 2023	Director
SLRN	ACELYRIN, Inc.	May 4, 2023	0	$0	3	May 4, 2023	Director
APTX	Aptinyx Inc.	May 26, 2022	1	$0	4	May 31, 2022	Director
ABBV	AbbVie Inc.	May 16, 2022	3	-$13M	4/A	May 20, 2022	EVP, Chief Strategy Officer
ABBV	AbbVie Inc.	Mar 1, 2022	4	-$3.68M	4/A	May 20, 2022	EVP, Chief Strategy Officer
ABBV	AbbVie Inc.	Feb 25, 2022	4	-$6.73M	4	Mar 1, 2022	EVP, Chief Strategy Officer
ABBV	AbbVie Inc.	Feb 17, 2022	5	$0	4	Feb 22, 2022	EVP, Chief Strategy Officer
ABBV	AbbVie Inc.	Sep 7, 2021	2	$0	4	Sep 10, 2021	EVP, Chief Strategy Officer
APTX	Aptinyx Inc.	May 27, 2021	1	$0	4	Jun 1, 2021	Director